Angelle Williams
Family · Gonzales, LANPI 1104551225
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,437, 3.7 times the $388 reported in 2023.
Across 124 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$586
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$452
- Lilly USA, LLC$368
- AstraZeneca$205
- Novo Nordisk$193
- Otsuka America Pharmaceutical, Inc.$180
- plus $959 from 24 others
What the payments were for
- Food & beverage$2,943100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 31 | $586 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $452 |
| Lilly USA, LLC | 17 | $368 |
| AstraZeneca | 8 | $205 |
| Novo Nordisk | 6 | $193 |
| Otsuka America Pharmaceutical, Inc. | 9 | $180 |
| Viiv Healthcare Company | 1 | $122 |
| Axsome Therapeutics, Inc. | 3 | $78 |
| Dexcom, Inc. | 3 | $76 |
| Ardelyx, Inc. | 3 | $71 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| GSK | 3 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $49 |
| Cequr Corporation | 2 | $46 |
| Organon | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Theratechnologies Inc. | 1 | $37 |
| Insulet Corporation | 2 | $35 |
| Merck | 2 | $31 |
| Amgen | 2 | $28 |
| Abbott | 1 | $25 |
| Ironwood Pharmaceuticals, Inc | 1 | $21 |
| Abiomed | 1 | $20 |
| Exact Sciences | 1 | $20 |
| Bayer | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $18 |
| Biogen | 1 | $16 |
| Boehringer Ingelheim | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Vertex | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,943 in reported general payments places this provider in the 80th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $775 |
| Gabapentin | 29 | $220 |
| Atorvastatin Calcium | 31 | $208 |
| Metformin Hcl ErMetformin Hcl | 18 | $203 |
| Losartan Potassium | 16 | $146 |
| Omeprazole | 14 | $145 |
| Trazodone Hcl | 21 | $118 |
| Sertraline Hcl | 18 | $62 |
| Ibuprofen | 15 | $56 |
| Tizanidine Hcl | 15 | $49 |
| Lisinopril | 13 | $29 |
| Amlodipine Besylate | 20 | $27 |
| Pantoprazole Sodium | 16 | $26 |
| Metoprolol Succinate | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in Gonzales
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.